2016
DOI: 10.3892/ijo.2016.3334
|View full text |Cite
|
Sign up to set email alerts
|

The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo

Abstract: Activated ras genes are found in a large number of human tumors, and therefore are one of important targets for cancer therapy. This study investigated the antitumor effects of a novel single chain fragment variable antibody (scFv) against ras protein, p21Ras. The anti-p21Ras scFv gene was constructed by phage display library from hybridoma KGHR1, and then subcloned into replication-defective adenovirus vector to obtain recombinant adenovirus KGHV100. Human tumor cell lines with high expression of p21Ras SW480… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 37 publications
0
18
0
Order By: Relevance
“…ScFvs play an important role in the diagnosis and treatment of diseases (Wang et al 2016b ). They can be used as powerful tools that directly target specific antigens to exert strong antitumoral effects and can also be used to visualize tumor masses in vivo (Duranti et al 2018 ; Yang et al 2016 ). Therefore, passive immunization with scFvs directed against PEDV may be an effective strategy for controlling PEDV infection.…”
Section: Introductionmentioning
confidence: 99%
“…ScFvs play an important role in the diagnosis and treatment of diseases (Wang et al 2016b ). They can be used as powerful tools that directly target specific antigens to exert strong antitumoral effects and can also be used to visualize tumor masses in vivo (Duranti et al 2018 ; Yang et al 2016 ). Therefore, passive immunization with scFvs directed against PEDV may be an effective strategy for controlling PEDV infection.…”
Section: Introductionmentioning
confidence: 99%
“…However, no targeted drugs that target against p21Ras directly have been exploited. Recently, we prepared a novel anti-p21Ras Mab, KGH-R1, which can recognize and react with three type of p21Ras, including H-p21Ras, N-p21Ras and K-p21Ras, and the single chain antibody derived from this Mab could regress p21Ras-overexpressing tumors in vitro and in vivo (26,42). In this study, the Mab was employed to examine p21Ras expression in normal colorectal epithelium, inflammatory polyps, low-grade intraepithelial neoplasia, high-grade intraepithelial neoplasia and invasive CRC.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, the membranes were washed and incubated with a goat anti-mouse/rabbit IgG antibody and horseradish peroxidase (HRP) (ZSGB-Bio, ZB-5305, China) at 37°C for 45 min. After washing with TBST, the protein bands were visualized with a 3,3'-diaminobenzidine chemiluminescence system (ZSGB-Bio) [29].…”
Section: Detection Of the Immunoreactivity Of Rgd4c-p21ras Scfvmentioning
confidence: 99%
“…Mutated p21Ras proteins become key drivers in the development of cancers [26,27]. Moreover, wild-type p21Ras overexpression is an important cause of colorectal cancer [28], and the expression rate of p21Ras has been found to reach 29% -76% [29]. p21Ras could become a promising therapeutic target for colorectal cancer treatment.…”
Section: Introductionmentioning
confidence: 99%